logo
Not all brands are onboard with ditching synthetic dyes

Not all brands are onboard with ditching synthetic dyes

The Hill10 hours ago
Major American brands have vowed to remove synthetic food dyes from their products, but M&M's and Skittles, made by Mars, remain colorful holdouts.
Mars has continued to use synthetic dyes in its candies after backing off a 2016 plan to remove all artificial colors from its food portfolio.
The company reversed course after it found that consumer attitudes varied by country, with Europeans largely opposed to synthetic dyes, while others preferred artificially colored treats, according to the Mars website.
Synthetic dyes have come under fire recently from Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who wants them removed from the nation's food supply over potential health risks.
Some research has linked the dyes to behavioral health issues in children and places like Australia, Canada and the European Union generally have tighter restrictions on their use.
Despite those concerns, synthetic dyes remain widespread, appearing in nearly 1 in 5 packaged foods and beverages on U.S. grocery shelves, according to a recent study.
That study, published in the Journal of the Academy of Nutrition and Dietetics, found that confectionery companies had the most products containing synthetic dyes.
The National Confectioners Association, a candy industry trade group, criticized the study, accusing the authors of having 'major gaps in their analysis.' The NCA argued that chocolate and candy differ from other foods because Americans eat them less frequently, only two to three times per week.
Both Skittles and M&M's list several synthetic dyes on their ingredient labels, including common dyes like Red 40, Yellow 5 and Yellow 6. Mars did not respond to NewsNation's request for comment on Tuesday.
So far, Kennedy has favored the carrot over the stick, encouraging companies to voluntarily phase out synthetic dyes rather than pushing for major changes in federal regulation. Recent announcements suggest the approach is gaining traction.
Food giants like Kraft Heinz, General Mills, PepsiCo, Nestle and ConAgra have all unveiled plans to move away from artificial colors in their U.S. products. The question is whether they'll follow through.
Thomas Galligan, principal scientist for food additives at the Center for Science in the Public Interest, has expressed skepticism, noting that many companies have failed to keep similar promises in the past.
'If the FDA were to require warning labels on synthetically dyed foods, similar to the rule in place since 2010 in the European Union, there would be a much stronger incentive for industry to reformulate,' Galligan said in a recent statement.
Several states have taken matters into their own hands, passing legislation restricting synthetic dyes. In West Virginia, most artificial food dyes will be banned starting in 2028. California and Virginia have banned six artificial dyes from school food.
Meanwhile, beginning in 2027, Texas will require warning labels on foods or beverages made with any of more than 40 dyes or additives.
'We follow and will continue to follow regulatory guidance from the authorities in this space because consumer safety is our chief responsibility and priority,' the National Confectioners Association said in an April statement responding to Kennedy's push to phase out synthetic food dyes.
While several artificial dyes remain, Mars has removed another controversial additive, titanium dioxide, from Skittles.
The chemical, which helps make candy appear shiny, was removed from all Skittles production at the end of last year, the company confirmed to Bloomberg in May. The ingredient was already banned in the European Union in 2022 over possible health risks.
According to its website, Mars is still committed to avoiding synthetic colors in its dinnertime foods.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DOJ subpoenas more than 20 gender-affirming care doctors, clinics
DOJ subpoenas more than 20 gender-affirming care doctors, clinics

UPI

time38 minutes ago

  • UPI

DOJ subpoenas more than 20 gender-affirming care doctors, clinics

The Justice Department on Wednesday announced it was subpoenaing more than 20 doctors and clinics that perform gender-affirming care for minors as the Trump administration ramps up its attacks against this marginalized group of Americans. File Photo by Terry Schmitt/UPI | License Photo July 9 (UPI) -- The Justice Department on Wednesday announced that it had sent more than 20 subpoenas to doctors and clinics performing gender-affirming care for minors, as the Trump administration ramps up its attacks on this marginalized community. No information about the doctors and clinics subpoenaed was provided by the Justice Department, though it suggested the subpoenas were part of investigations into "healthcare fraud, false statements and more." "Medical professionals and organizations that mutilate children in the service of a warped ideology will be held accountable by this Department of Justice," Attorney General Pam Bondi said in a statement. On June 18, the Supreme Court upheld a Tennessee law restricting access to gender-affirming care for minors. The subpoenas come despite every major American medical association supporting gender-affirming care for both adults and youth, including the American Academy of Pediatrics. Gender-affirming care includes a range of therapies, from psychological, behavioral and medical interventions, with surgeries for minors being exceedingly rare. According to a recent Harvard study, cisgender minors and adults were far more likely to undergo analogous gender-affirming surgeries than their transgender counterparts. Despite the support of the medical community and the evidence, conservatives, Republicans and the Trump administration have continued to target this community with legislation affecting their medical care and rights. The subpoenas were announced the same day that the Federal Trade Commission hosted a day-long workshop titled "The Dangers of Gender-Affirming Care for Minors," during which Melissa Holyoak, an FTC commissioner, said that while they cannot make policy decisions limiting gender-affirming care, they can target the medical practice for deceptive statements. "The FTC has previously enforced -- and will continue to enforce -- against deceptive representations made by medical practitioners, including claims in connection with treatments for transgender children," she said, according to a copy of her remarks. Also on Wednesday, the Department of Justice sued California over alleged Title IX violations concerning transgender athletes competing in women's and girls' sports. The Democratic-led state has refused to comply with the Trump administration's ban on transgender women and girls competing in sports that align with their gender identity. Since returning to the White House in January, President Donald Trump has signed several executive orders targeting transgender Americans, including one directing the federal government to recognize only two sexes determined at "conception," another restricting gender-affirming care for youth and a third banning transgender Americans from the military.

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks

Yahoo

time2 hours ago

  • Yahoo

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the American Public Health Association (APHA), filed a lawsuit on Monday against Secretary of Health and Human Services Robert F. Kennedy Jr. The plaintiffs contend that Secretary Kennedy has launched an 'assault on science, public health, and evidence-based medicine' through unilateral and arbitrary changes to COVID-19 vaccine recommendations for children and pregnant individuals. This unprecedented legal action seeks to halt what the coalition describes as an 'existential threat to vaccination in America,' arguing that Kennedy's directives, including the controversial dismissal of expert advisors from the CDC's immunization committee, are endangering the nation's long-standing, science-based vaccine infrastructure and, critically, the health of its most vulnerable populations. Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — The comprehensive lawsuit, filed in the U.S. District Court for the District of Massachusetts, names the U.S. Department of Health and Human Services (HHS) and Secretary Robert F. Kennedy Jr. as defendants. The plaintiffs, which also include the Infectious Diseases Society of America (IDSA), the Massachusetts Public Health Alliance (MPHA), the Society for Maternal-Fetal Medicine (SMFM), and a pregnant physician, assert that Kennedy acted 'arbitrarily and capriciously' by altering COVID-19 vaccine recommendations for children and pregnant people without scientific basis. This follows Secretary Kennedy's public statement in May, where he expressed pleasure at the removal of the COVID-19 vaccine for healthy children and pregnant women from CDC recommended immunization schedules. A critical aspect of the lawsuit's complaint is Secretary Kennedy's alleged unjust dismissal of 17 members of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP). These experts were reportedly replaced with individuals known for espousing anti-vaccine viewpoints. Dr. Susan J. Kressly, President of the AAP, underscored the gravity of these actions, stating, 'This wasn't just sidelining science. It's an attack on the very foundation of how we protect families and children's health. And the consequences could be dangerous.' The lawsuit further details a pattern of interference, including blocked CDC communications, delayed or canceled meetings of CDC and Food and Drug Administration (FDA) vaccine advisers, and the announcement of studies to investigate non-existent links between vaccines and plaintiffs are seeking both preliminary and permanent injunctions to reverse Secretary Kennedy's rescissions of COVID-19 vaccine recommendations. They also request a declaratory judgment to legally pronounce these changes as unlawful. Richard H. Hughes IV, lead counsel for the plaintiffs and partner at Epstein Becker Green, voiced grave concerns, asserting, 'This administration is an existential threat to vaccination in America, and those in charge are only just getting started. If left unchecked, Secretary Kennedy will accomplish his goal of ridding the United States of vaccines, which would unleash a wave of preventable harm on our nation's children.' The lawsuit alleges that the Directive is but one example of the Secretary's agenda to dismantle the long-standing, Congressionally-authorized, science- and evidence-based vaccine infrastructure that has prevented the deaths of untold millions of Americans. The filing highlights that the Secretary's dismantling of the vaccine infrastructure must end, and halting this effort begins with vacating the Directive. Per a recent media report, Dr. Vinay Prasad, the U.S. Food and Drug Administration's (FDA) top vaccine official, overruled agency scientists to limit approval of two COVID-19 vaccines, despite internal recommendations to clear them for broader use. FDA scientists had recommended full approval for updated COVID vaccines from Novavax Inc. (NASDAQ:NVAX) and Moderna Inc. (NASDAQ:MRNA) for individuals aged 12 and older, citing favorable risk-benefit analyses. But Prasad restricted the shots to those at higher risk, seniors and people with underlying health conditions, arguing that declining hospitalization and death rates from COVID-19 shifted the balance of risks and benefits. While distinct from the HHS lawsuit, this report underscores a broader climate of scrutiny and debate surrounding vaccine policy. The AAP has a history of pursuing legal action against the federal government, regardless of political affiliation. Past instances include a 1983 lawsuit against HHS regarding life-sustaining treatment for infants and separate lawsuits against the FDA in 2016 and 2018 concerning graphic warnings on cigarettes and e-cigarette regulation, respectively. Read Next: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — And You Can Invest At Just $6.37/Share Bezos' Favorite Real Estate Platform Launches A Way To Ride The Ongoing Private Credit Boom Photo by lev radin via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The Surprising Food to Eat More of If You Have Diabetes, According to a New Study
The Surprising Food to Eat More of If You Have Diabetes, According to a New Study

Yahoo

time3 hours ago

  • Yahoo

The Surprising Food to Eat More of If You Have Diabetes, According to a New Study

Reviewed by Dietitian Annie Nguyen, M.A., RDA study suggests sesame may help improve blood sugar and cholesterol in people with diabetes. Sesame products—like oil, seeds or tahini—could support heart health when used consistently. While promising, the evidence is lower-quality, so speak with a healthcare provider before making any major disease is a top health concern for good reason—it's the leading cause of death worldwide. And if you're among the 38.4 million American adults who are living with diabetes, your risk is even higher. That's because diabetes doesn't just affect blood sugar—it also contributes to a cascade of problems that raise the chances of having a heart attack or stroke. These include high levels of LDL ('bad') cholesterol, elevated triglycerides and chronic oxidative stress, which damages blood vessels over time. Finding simple, effective ways to reduce this risk is a major priority in diabetes care. One promising approach researchers have been exploring is food—especially foods with bioactive compounds that go beyond basic nutrition. Sesame (yes, the same seed you'll find on buns and bagels) has been a key ingredient in many diets for centuries and contains powerful compounds like sesamin and sesamol that act as antioxidants and support heart and metabolic health. Until now, studies on sesame's health benefits have been relatively small and inconsistent. But a new meta-analysis published in Diabetes & Metabolic Syndrome: Clinical Research and Reviews brings together the results of 13 clinical trials to take a closer look. The researchers focused on people with diabetes and evaluated how sesame products affected a wide range of cardiovascular risk factors, including blood sugar, cholesterol levels and markers of oxidative stress. Their findings suggest sesame may do more than add flavor—it could also play a meaningful role in protecting your heart. Researchers conducted a systematic review and meta-analysis, a study method that pools data from multiple past trials to look for patterns. They included 13 randomized controlled trials involving a total of 731 adults with diabetes. Most participants had type 2 diabetes, and the studies were conducted across several countries, including Iran, India, Brazil and Pakistan. Participants received sesame in various forms—such as sesame oil, whole seeds or capsules—at doses ranging from 200 to 60,000 milligrams per day. The interventions lasted between six and 12 weeks. The researchers measured outcomes like blood sugar, cholesterol, antioxidant activity, body weight and inflammation markers. They used the GRADE system, a formal framework for evaluating the strength of scientific evidence. Overall, the study found that sesame products were linked to significant improvements in several cardiovascular disease risk factors for people with diabetes. Specifically, sesame consumption: Lowered fasting blood glucose Reduced hemoglobin A1c (a measure of long-term blood sugar control) Decreased post-meal blood glucose Reduced LDL cholesterol Decreased total cholesterol and triglycerides Increased levels of two key antioxidant enzymes: catalase (CAT) and superoxide dismutase (SOD) These changes suggest that sesame may help regulate blood sugar, improve lipid profiles and protect against oxidative stress—three critical goals in managing diabetes and reducing the risk of heart disease. However, not all findings were positive. The researchers didn't find significant improvements in HDL ('good') cholesterol, insulin resistance, inflammation markers like C-reactive protein or blood pressure. In addition, the effects appeared to diminish once sesame supplementation stopped, suggesting ongoing use may be necessary. It's worth noting that the quality of evidence in this study was rated 'very low' due to limitations like small sample sizes, short trial durations, inconsistent results and risk of bias in study design. That means while the findings are promising, they should be interpreted with caution. That said, sesame is a safe and nutritious ingredient to include in your diet, even if these specific heart-health benefits aren't fully confirmed. It's rich in healthy fats, fiber and antioxidants, and previous studies have linked it to lower inflammation, improved blood pressure and better cholesterol levels. If you're living with diabetes or concerned about heart health, adding sesame products to your diet could be a simple, budget-friendly step with potential upside. In the reviewed studies, most benefits were seen with higher doses (around 30 grams per day) and longer use (eight weeks or more), so consistency matters. Try adding sesame oil to stir-fries or salad dressings, sprinkling toasted seeds over vegetables and grains or using tahini in sauces, dips and smoothies. Crushed or blended sesame (like tahini or sesame oil) may offer more benefits than whole seeds, since grinding improves the bioavailability of beneficial compounds like sesamin. Of course, sesame isn't a magic bullet. It should be part of a broader strategy that includes medical treatment, physical activity and a balanced diet. And if you're on medications for blood sugar or cholesterol, check with your healthcare provider before starting any supplement. Sesame may offer heart-protective benefits for people with diabetes, according to a new meta-analysis. It helped improve blood sugar, cholesterol and antioxidant activity—three pillars of cardiovascular health. While the overall quality of the evidence is low, these findings add to a growing body of research suggesting that sesame could be a helpful addition to diabetes care. Incorporating sesame oil, tahini or seeds into your meals may be a flavorful and health-supportive choice worth exploring. Read the original article on EATINGWELL

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store